SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-18-005261
Filing Date
2018-01-24
Accepted
2018-01-24 19:18:38
Documents
1
Period of Report
2018-01-24

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 3591
  Complete submission text file 0001209191-18-005261.txt   6100
Mailing Address 2000 GALLOPING HILL ROAD KENILWORTH NJ 07033
Business Address 2000 GALLOPING HILL ROAD KENILWORTH NJ 07033 908-740-4000
Merck & Co., Inc. (Reporting) CIK: 0000310158 (see all company filings)

State of Incorp.: NJ | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 001-38356 | Film No.: 18546378
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences

Mailing Address ONE MERCK DRIVE WHITEHOUSE STATION NJ 08889
Business Address ONE MERCK DRIVE WHITEHOUSE STATION NJ 08889 908-740-4000
Merck Sharp & Dohme Corp. (Reporting) CIK: 0000942443 (see all company filings)

State of Incorp.: NJ | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 001-38356 | Film No.: 18546377

Mailing Address 4085 CAMPBELL AVENUE, SUITE 200 MENLO PARK CA 94025
Business Address 4085 CAMPBELL AVENUE, SUITE 200 MENLO PARK CA 94025 650-486-1416
Menlo Therapeutics, Inc. (Issuer) CIK: 0001566044 (see all company filings)

IRS No.: 453757789 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences